Clinical analysis of cardiac autonomic ganglion plexus ablation for bradyarrhythmia

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900027305

Enrollment

Unknown

Registered

2019-11-08

Start date

2019-11-07

Completion date

Unknown

Last updated

2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bradyarrhythmia

Interventions

1:cardiac autonomic ganglion plexus ablation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. With symptoms of dizziness, apopsychia, cardiopalmus, weakness, chest distress and shortage of breath; proved by ECG or holter to be caused by high grade atrioventricular block and sick sinus syndrome. With features of permanent pace maker implantation; 2. Atropine test for esophageal pacing (+); 3. Age range18-50.

Exclusion criteria

Exclusion criteria: 1. With well-diagnosed Sinus node lesions and atrioventricular heart block, hypertrophic cardiomyopathy, pulmonary hypertension, epilepsy, transient ischemic attack and subclavian vein theft syndrome; 2. Serious complications including myocardial infarction, NYHA heart function III-IV, diabetes and incurable diseases; 3. Previous cardiac surgery, catheter ablation and pace maker implantation.

Design outcomes

Primary

Measure	Time frame
macrobiochemistry;GAP43;TH;hs-CRP;blood routine examination;urine routine examination;stool routine examination;electrocardiogram;Echocardiography;Holter;esophageal pacing examination;collect general data of patients including demographic features;physical checkup;present medication;	—

Countries

China

Contacts

Public ContactTang Baopeng

Cardiac Pacing and Electrophysiology Department, the First Affiliated Hospital of Xinjiang Medical University

tangbaopeng111@163.com+86 13579881111

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026